Edesa Biotech, Inc.
EDSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540159
No open-market purchases or sales by Edesa Biotech, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $30.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Edesa Biotech, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 20 | 1 | 20 | +1 |
| Shares | 2.82M | 1 | 2.11M | −714.3K (−25.3%) |
| Value | $6.89M | $2 | $4.28M | −$2.61M (−37.9%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Edesa Biotech, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 584 | $1.19K | 0.00% |
| Raymond James Financial Inc | 29 | $59 | 0.00% |
| Global Retirement Partners, LLC | 25 | $51 | 0.00% |
| LRI Investments, LLC | 1 | $2 | 0.00% |
Sold out (3)
Institutions that held Edesa Biotech, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Stonepine Capital Management, LLC | 687,500 | $1.68M |
| CIBC World Markets Inc. | 19,999 | $48.8K |
| Avion Wealth | 242 | $0 |
Not filed for Q2 2025 yet (1)
Institutions that held Edesa Biotech, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Credit Agricole S A | 1 | $2 |